{"title": "Cost effectiveness of early cancer surveillance", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/health_policy.xml", "value": "Cost effectiveness of early cancer surveillance"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/02/190204140621.htm"}], "link": "https://www.sciencedaily.com/releases/2019/02/190204140621.htm", "summary": "New research shows how early cancer screening and surveillance in patients with Li-Fraumeni syndrome (LFS) results in additional years of life, and is cost effective for third-party payers.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/health_policy.xml", "value": "New research shows how early cancer screening and surveillance in patients with Li-Fraumeni syndrome (LFS) results in additional years of life, and is cost effective for third-party payers."}, "published": "Mon, 04 Feb 2019 14:06:21 EST", "published_parsed": [2019, 2, 4, 19, 6, 21, 0, 35, 0], "id": "https://www.sciencedaily.com/releases/2019/02/190204140621.htm", "guidislink": false}